Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Prospect KC brews coffee bar collab with Messenger inside iconic downtown KC library
A reimagined coffee shop — closed during the pandemic — returns to full strength Aug. 7 thanks to a menu of pastries, sandwiches, and salads prepared by The Prospect KC culinary students in a live-training environment, as well as drinks and coolers crafted with Messenger Coffee Co. The 1,350-square-foot coffee bar and café — dubbed…
Cookies have taken over Sweet Kiss, but this mother-daughter brigadeiro shop has even more baked inside
For Jessica Harris, a brigadeiro offers a taste of home, she said, and for almost a decade, she’s been sharing those Brazilian truffles with Kansas City. When the Sweet Kiss Brigadeiro co-founder relocated to the City of Fountains in 1996 — following her sister who moved the year before to play basketball for Penn Valley…
Catalyst Fund tops $2M invested in nonprofits boosting people of color; meet the latest grantees
The latest batch of Catalyst Fund grants — a combined $500,000 across nearly two dozen organizations — seeks to elevate the work of small nonprofits that are led by or primarily serve Black, Latino, and other people of color across the region, said Dr. DeAngela Burns-Wallace. “Looking across the list of organizations in this third…
KC’s remaining shopping malls face an economic crossroads (and starkly different futures)
Editor’s note: This story was originally published by Kansas City PBS/Flatland, a member of the Kansas City Media Collective, which also includes Startland News, KCUR 89.3, American Public Square, The Kansas City Beacon, and Missouri Business Alert. Click here to read the original story. Country Club Plaza, Oak Park Mall, Independence Center hit with similar challenges The…